Across TCGA pan-cancer cohorts, MIR548I4 Mutation is linked to patient survival in 1 of 34 cancer types, making it a survival-associated MIR548I4 data layer compared with 6 for mass-spec protein.

The strongest signal is observed in mesothelioma (MESO), where higher MIR548I4 Mutation is associated with worse disease-free survival. In most high-consensus cancer types, elevated MIR548I4 expression acts as an unfavorable survival marker.

MESO are the cancer types where MIR548I4 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
MESO	DFS	Median	III,IV	0.078	0.376	.012	9	view →

Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

Exploration

Same gene, other analysis: MIR548I4 tumor-vs-normal RNA expression · all MIR548I4 data types